“Viking Therapeutics stock jumps more than 15% on promising weight loss pill data”
March 29, 2024
“Viking Therapeutics shares closed more than 15% higher on Tuesday after the company said its experimental weight loss pill showed positive results in a small study and will enter the next stage of development later this year…
Viking is one of several small biotech companies hoping to compete with Novo Nordisk and Eli Lilly in the space, which analysts say could grow into a $100 billion market by the end of the decade. Some analysts view Viking as a particularly strong potential player, or takeover target for a larger company…”